Abstract
We carried out a study to evaluate treatment response and residual mass in lung cancer with positron emission tomography (PET), using l-[methyl-11C]methionine (MET). MET tumour uptake and tumour volume measured by computed tomography (CT) before and within 2 weeks after radiotherapy or chemoradiotherapy were compared in 43 studies of 21 patients. Ten patients with local control (no recurrence) of tumour showed a larger decrease in MET uptake (65.2%±12.2%) than in tumour volume (50.8%±9.6%, P<0.01). Five patients with early recurrence (from 1 to 4 months) showed smaller decreases in both MET uptake (22.2%±13.5%) and tumour volume (28.6%±20.0%) than those in the no-recurrence group (P<0.01). Four patients with late recurrence (after 11 months or more) showed a similar decrease to the no-recurrence group in MET uptake (72.8%±14.8%) but little change in tumour volume (18.5%±19.0%), the latter result corresponding to that in the early-recurrence group. Using tumour volume only, the no-recurrence group was differentiated from both the early- and the late-recurrence group (P < 0.01), but the early-recurrence group was not differentiated from the late-recurrence group. Using the MET uptake data, the early-recurrence group was clearly distinguished from the late-recurrence group (P<0.01), but the late-recurrence group was indistinguishable from the no-recurrence group. CT was useful in distinguishing the no-recurrence group from the groups in which there was ultimate recurrence, whether early or late. When a residual mass is seen on CT, PET seems to be helpful in evaluating tumour viability.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Steel GG. Cell population kinetics of tumours in experimental animals. In: Steel GG, ed. Growth kinetics of tumours. Oxford: Clarendon Press; 1977:146–184
Minn H, Paul R, Ahonen A. Evaluation of treatment response to radiotherapy in head and neck cancer with fluorine-18 fluorodeoxyglucose. J Nucl Med 1988;29:1521–1525
Minn H, Soini I. 18F fluorodeoxyglucose scintigraphy in diagnosis and follow up of treatment in advanced breast cancer. Eur J Nucl Med 1989;15:61–66
Abe Y, Matsuzawa T, Fujiwara T, et al. Clinical assessment of therapeutic effects on cancer using 18F-2-fluoro-2-doexy-d-glucose and positron emission tomography: preliminary study of lung cancer. Int J Radiat Oncol Biol Phys 1990;19:1005–1010
Nagata Y, Yamamoto K, Hiraoka M, et al. Monitoring liver tumor therapy with [18F]FDG positron emission tomography. J Comput Assist Tomogr 1990;14:370–374
Okazumi S, Isono K, Enomoto K, et al. Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment. J Nucl Med 1992;33:333–339
Haberkorn U, Strauss LG, Dimitrakopoulou A, et al. PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. J Nucl Med 1991;32:1485–1490
Engenhart R, Kimming BN, Strauss LG, et al. Therapy monitoring of presacral recurrences after high-dose irradiation: value of PET, CT, CEA and pain score. Strahlenther Onkol 1992;168:203–212
Ichiya Y, Kuwabara Y, Otsuka M, et al. Assessment of response to cancer therapy using fluorine-l8-fluorodeoxyglucose and positron emission tomography. J Nucl Med 1991;32:1655–1660
Bergström M, Muhr C, Lundberg PO, et al. Rapid decrease in amino acid metabolism in prolactin-secreting pituitary adenomas after bromocriptine treatment: a PET study. J Comput Assist Tomogr 1987;11:815–819
Derlon JM, Bourdet C, Bustany P, et al. [11C]l-methionine uptake in gliomas. Neurosurgery 1989;25:720–728
Leskinen-Kallio S, Minn H, Joensuu H. PET and [11C]methionine in assessment of response in non-Hodgkin lymphoma. Lancet 1990;336:1188
Kubota K, Yamada S, Ishiwata K, et al. Positron emission tomography for treatment evaluation and recurrence detection compared to CT in long follow-up case of lung cancer. Clin Nucl Med 1992;17:877–881
Mountain CF. The new international staging system for lung cancer. Surg Clin North Am 1987;67:925–935
Ishiwata K, Ido T, Abe Y. Tumor uptake studies of S-adenosyl-l-[methyl-11C]methionine and l-[methyl-11C]methionine. Int J Rad Appl Instrum [B] 1988;15:123–126
Kubota K, Matsuzawa T, Fujiwara T, et al. Differential diagnosis of lung tumor with positron emission tomography: a prospective study. J Nucl Med 1990;31:1927–1933
Ishiwata K, Vaalburg W, Elsinga PH. Comparison of l-[1-11C]methionine and l-methyl-[11C]methionine for measuring in vivo protein synthesis rates with PET. J Nucl Med 1988; 29:1419–1427
Ullrich RL, Casarett GW. Interrelationship between the early inflammatory response and subsequent fibrosis after radiation exposure. Radiat Res 1977;72:107–121
Kubota R, Yamada S, Kubota K, et al. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992;33:1972–1980
Kubota K, Ishiwata K, Kubota R, et al. Tracer feasibility for monitoring of tumor radiotherapy: quadruple-tracer study with fluorine-l8-fluorodeoxyglucose or fluorine-18-fluorodeoxyuridine, l-methyl-14C methionine, 6-3H thymidine, and gallium-67. J Nucl Med 1991;32:2118–2123
Kubota K, Matsuzawa T, Takahashi T, et al. Rapid and sensitive response of carbon-11-l-methionine tumor uptake to irradiation. J Nucl Med 1989;30:2012–2016
Kubota K, Ishiwata K, Yamada S, et al. Dose-responsive effect of radiotherapy on the tumor uptake of l-[methyl-11C]methionine; feasibility for monitoring recurrence of tumor. Int J Rad Appl Instrum [B] 1992;19:123–126
Hall EJ. Time, dose, and fractionation in radiotherapy. In: Hall EJ, ed. Radiobiology for the radiologist, 3rd edn. Philadelphia: Lippincott; 1988:240–259
Peters LJ, Brock WA, Chapman JD, et al. Predicitive assays of tumor radiocurability. Am J Clin Oncol 1988;11:275–287
Johnson DH, Einhorn LH, Bartolucci A, et al. Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer. Ann Intern Med 1990;113:33–38
Perez CA, Pajak TF, Rubin P, et al. Long-term observations of the patterns of failure on patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Cancer 1987;59:1874–1881
Leskinen-Kallio S, Någren K, Lehikoinen P, et al. Uptake of 11C-methionine in breast cancer studied by PET. An association with the size of S-phase fraction. Br J Cancer 1991; 64:1121–1124
Leskinen-Kallio S, Ruotsalainen U, Nagren K, et al. Uptake of carbon- 11-methionine and fluorodoxyglucose in non-Hodgkin's lymphoma: a PET study. J Nucl Med 1991;32:1211–1218
Leskinen-Kallio S, Någren K, Lehikoinen P, et al. Carbon-11-methionine and PET is an effective method to image head and neck cancer. J Nucl Med 1992;33:691–695
Author information
Authors and Affiliations
Additional information
Correspondence to: K. Kubota
Rights and permissions
About this article
Cite this article
Kubota, K., Yamada, S., Ishiwata, K. et al. Evaluation of the treatment response of lung cancer with positron emission tomography and l-[methyl-11C]methionine: a preliminary study. Eur J Nucl Med 20, 495–501 (1993). https://doi.org/10.1007/BF00175162
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00175162